Fusion detection and longitudinal circulating tumor DNA (ctDNA) profiling in ALK+ non-small cell lung cancer (NSCLC) patients.

Aurélie Swalduz,Sandra Ortiz-Cuaran,Virginie Avrillon,Solène Marteau,Séverine Martinez,Gilles Clapisson,Laure Montane,David Pérol,Emma Green,Karen Howarth,Frank de Kievit,Clive D. Morris,M. Perol,Pierre Saintigny

Fusion detection and longitudinal circulating tumor DNA (ctDNA) profiling in ALK+ non-small cell lung cancer (NSCLC) patients.

2018

Aurélie Swalduz
Sandra Ortiz-Cuaran
Virginie Avrillon
Solène Marteau
Séverine Martinez
Gilles Clapisson
Laure Montane
David Pérol
Emma Green
Karen Howarth
Frank de Kievit
Clive D. Morris
M. Perol
Pierre Saintigny

e21031Background: Therapeutic response in ALK+ NSCLC is driven by heterogeneous mechanisms of resistance. Liquid biopsy (LB) offers a non-invasive approach to study the tumor genomic landscape unde...

Keywords:

non-small cell lung cancer (NSCLC)
Circulating tumor DNA
Pathology
Cancer research
Medicine
Liquid biopsy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations